These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33673284)

  • 1. Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel.
    Ando K; Sakamoto S; Saito S; Maimaiti M; Imamura Y; Sazuka T; Sato N; Komiya A; Anzai N; Ichikawa T
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxel.
    Ando K; Sakamoto S; Takeshita N; Fujimoto A; Maimaiti M; Saito S; Sanjyon P; Imamura Y; Sato N; Komiya A; Akakura K; Ichikawa T
    Prostate; 2020 Feb; 80(3):247-255. PubMed ID: 31816126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients.
    Stangl-Kremser J; Mari A; Suarez-Ibarrola R; D'Andrea D; Korn SM; Pones M; Kramer G; Karakiewicz P; Enikeev DV; Glybochko PV; Briganti A; Shariat SF
    Urol Oncol; 2020 Jun; 38(6):600.e9-600.e15. PubMed ID: 31953003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer.
    Hanai N; Sawabe M; Kimura T; Suzuki H; Ozawa T; Hirakawa H; Fukuda Y; Hasegawa Y
    Oncotarget; 2018 Dec; 9(97):37008-37016. PubMed ID: 30651931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort.
    Neuberger M; Goly N; Skladny J; Milczynski V; Weiß C; Wessels F; Nitschke K; Grüne B; Haney CM; Hartung F; Herrmann J; Jarczyk J; Kowalewski KF; Waldbillig F; Kriegmair MC; Westhoff N; Worst TS; Nuhn P
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3371-3381. PubMed ID: 35939112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
    Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
    Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
    Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
    [No Abstract]   [Full Text] [Related]  

  • 10. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer.
    Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
    Oncology; 2014; 87(4):205-14. PubMed ID: 25034097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy.
    Chen P; Fang M; Wan Q; Zhang X; Song T; Wu S
    Oncotarget; 2017 Nov; 8(59):99861-99870. PubMed ID: 29245945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy.
    Neuberger M; Skladny J; Goly N; Wessels F; WEIß C; Egen L; Erben P; GROß-Weege M; Grüne B; Hartung F; Herrmann J; Honeck P; Jarczyk J; Kowalewski KF; Mühlbauer J; Nitschke K; Nientiedt M; Walach MT; Waldbillig F; Westhoff N; VON Hardenberg J; Kriegmair M; Worst TS; Nuhn P
    Anticancer Res; 2022 Apr; 42(4):1911-1918. PubMed ID: 35347010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy.
    Shigeta K; Kosaka T; Kitano S; Yasumizu Y; Miyazaki Y; Mizuno R; Shinojima T; Kikuchi E; Miyajima A; Tanoguchi H; Hasegawa S; Oya M
    Ann Surg Oncol; 2016 Nov; 23(12):4115-4122. PubMed ID: 27364499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score.
    Nakamura T; Asanuma K; Hagi T; Sudo A
    J Inflamm Res; 2022; 15():3891-3899. PubMed ID: 35845092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study.
    Tsai YT; Fang KH; Hsu CM; Lai CH; Chang SW; Huang EI; Tsai MS; Chang GH; Luan CW
    Front Oncol; 2022; 12():825967. PubMed ID: 35242712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
    Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
    J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the Modified and High-Sensitivity Modified Glasgow Prognostic Scores for Hypopharyngeal Squamous Cell Carcinoma.
    Iuchi H; Ohori J; Matsuzaki H; Kiyama S; Yamashita M
    OTO Open; 2021; 5(4):2473974X211067423. PubMed ID: 34950840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of handgrip strength and high-sensitivity modified Glasgow prognostic score predicts survival outcomes in patients with colon cancer.
    Shi Y; Sun Y; Shen X; Yang Z; Xu B; Bao C
    Front Nutr; 2024; 11():1421560. PubMed ID: 39010859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of systemic inflammation and nutrition-based prognostic indices in oropharyngeal carcinoma.
    Oka T; Sato F; Ono T; Kawaguchi T; Murotani K; Sueyoshi S; Kuroiwa T; Kurita T; Fukahori M; Mitsuhashi T; Sato K; Chitose SI; Umeno H
    Laryngoscope Investig Otolaryngol; 2023 Jun; 8(3):675-685. PubMed ID: 37342125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis.
    Wu TH; Tsai YT; Chen KY; Yap WK; Luan CW
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.